These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8350210)
1. Effects of cerulein and epidermal growth factor on pancreatic growth in the reserpinized rat model. Bérubé FL; Benrezzak O; Vanier M; Morisset J J Pediatr Gastroenterol Nutr; 1993 Jul; 17(1):39-48. PubMed ID: 8350210 [TBL] [Abstract][Full Text] [Related]
2. Alterations of pancreatic amylase secretion in the reserpinized rat model of cystic fibrosis. Effects of cerulein and EGF. Morisset J; Bérubé FL; Vanier M; Benrezzak O Int J Pancreatol; 1994 Aug; 16(1):37-44. PubMed ID: 7528761 [TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor inhibits rat pancreatic cell proliferation, causes acinar cell hypertrophy, and prevents caerulein-induced desensitization of amylase release. Morisset J; Larose L; Korc M Endocrinology; 1989 Jun; 124(6):2693-8. PubMed ID: 2470581 [TBL] [Abstract][Full Text] [Related]
4. Excessive doses of cerulein stimulate pancreatic growth in suckling rats but damage the pancreas of weaned rats. Papp M; Dobronyi I; Varga G Biol Neonate; 1988; 54(6):339-46. PubMed ID: 2465788 [TBL] [Abstract][Full Text] [Related]
5. Lack of effect of cerulein on pancreatic growth of rats fed a low-protein diet. Green GM; Sarfati PD; Morisset J Pancreas; 1991 Mar; 6(2):182-9. PubMed ID: 1715991 [TBL] [Abstract][Full Text] [Related]
8. Alterations of amylase secretion in the chronically reserpinized rat: an acetylcholine-mediated phenomenon. Benrezzak O; Bérubé FL; Morisset J Pancreas; 1991 Nov; 6(6):679-87. PubMed ID: 1723525 [TBL] [Abstract][Full Text] [Related]
9. Glucagon inhibition of cerulein-induced hypertrophy of the exocrine pancreas. Kash FF; Wood JG; Solomon T Pancreas; 1988; 3(1):11-7. PubMed ID: 3362838 [TBL] [Abstract][Full Text] [Related]
10. Effects of reserpine treatment on dietary adaptation of the rat exocrine pancreas. Hazlett DA; Brannon PM Pediatr Res; 1988 Feb; 23(2):176-80. PubMed ID: 2451206 [TBL] [Abstract][Full Text] [Related]
11. Peptide YY ameliorates cerulein-induced pancreatic injury in the rat. Tito JM; Rudnicki M; Jones DH; Alpern HD; Gold MS Am J Surg; 1993 Jun; 165(6):690-6. PubMed ID: 7685154 [TBL] [Abstract][Full Text] [Related]
13. Effects of malnutrition and chronic reserpine treatment on pancreatic exocrine function. Hazlett D; Korc M; Brannon PM Pediatr Res; 1986 Dec; 20(12):1236-9. PubMed ID: 2432455 [TBL] [Abstract][Full Text] [Related]
14. Alterations of pancreatic growth and of GP-2 content in the reserpinized rat model of cystic fibrosis. Leblond FA; Morisset J; LeBel D Pediatr Res; 1989 May; 25(5):478-81. PubMed ID: 2717264 [TBL] [Abstract][Full Text] [Related]
15. Plasma immunoreactive cationic trypsin(ogen) pattern in reserpinized rat model of cystic fibrosis. Resemblance to humans. Weizman Z Dig Dis Sci; 1996 May; 41(5):853-8. PubMed ID: 8625754 [TBL] [Abstract][Full Text] [Related]
17. Effects of cerulein on the normal pancreas and on experimental pancreatic carcinoma in the Syrian golden hamster. Satake K; Mukai R; Kato Y; Umeyama K Pancreas; 1986; 1(3):246-53. PubMed ID: 2437568 [TBL] [Abstract][Full Text] [Related]
18. Dissimilar trophic effects of cerulein and xenopsin on the rat pancreas. Feurle GE; Ohnheiser G; Löser C Int J Pancreatol; 1990 Mar; 6(2):129-37. PubMed ID: 2230360 [TBL] [Abstract][Full Text] [Related]
19. The importance of the centroacinar region in cerulein-induced mouse pancreatic growth. Gasslander T; Ihse I; Smeds S Scand J Gastroenterol; 1992 Jul; 27(7):564-70. PubMed ID: 1641582 [TBL] [Abstract][Full Text] [Related]
20. Ethanol consumption and susceptibility of the pancreas to cerulein-induced pancreatitis. Ponnappa BC; Marciniak R; Schneider T; Hoek JB; Rubin E Pancreas; 1997 Mar; 14(2):150-7. PubMed ID: 9057187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]